|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$746,879
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
5K08CA133103-03
|
$140,940
|
Gutierrez, Alejandro
|
DANA-FARBER CANCER INSTITUTE
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-31S1
|
$97,935
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-32S1
|
$99,959
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-32
|
$1,889,710
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
X-RAR alpha proteins: Molecualr Pathogenesis of Acute Promyelocytic Leukemia
|
5R37CA071692-14
|
$348,711
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-13
|
$360,039
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
VITAMIN D PLANT ANTIOXIDANT SILIBININ IN LEUKEMIA TRANSLATIONAL STUDY
|
5R01CA117942-04
|
$189,600
|
Studzinski, GEORGE
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy
|
5R01CA044722-20
|
$205,937
|
STUDZINSKI, GEORGE
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126 00580
|
$85,856
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VEGF Function in B-CLL
|
5R01CA116237-05
|
$271,511
|
Kay, Neil
|
MAYO CLINIC
|
|
VCU Minority-Based Community Clinical Oncology Program
|
2U10CA052784-20
|
$359,518
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S1
|
$100,001
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based Community Clinical Oncology Program
|
3U10CA052784-20S2
|
$197,549
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validating Syk as a Target for AML Therapy
|
5R01CA140292-02
|
$362,088
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INSTITUTE
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S1
|
$101,020
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-37S2
|
$148,912
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-37
|
$4,795,480
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center Lymphoma SPORE
|
5P50CA136411-02
|
$500,000
|
YOUNES, ANAS
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-22
|
$2,399,682
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S1
|
$99,949
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S2
|
$73,975
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-35S3
|
$98,980
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-35
|
$6,464,088
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
3U54CA096297-08S1
|
$200,000
|
Frontera, Walter
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
3U54CA096297-08S2
|
$225,768
|
Frontera, Walter
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096297-08
|
$1,543,594
|
Frontera, Walter
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research
|
5U54CA096300-08
|
$1,243,985
|
DUBOIS, RAYMOND
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-08
|
$2,158,273
|
ISSA, JEAN-PIERRE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Rochester Cancer Center CCOP Research Base
|
3U10CA037420-25S1
|
$192,830
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-26
|
$2,671,183
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of New Mexico Cancer Center Support
|
2P30CA118100-06
|
$2,035,899
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-05S6
|
$99,994
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-06S1
|
$39,736
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-06S2
|
$100,055
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-06S3
|
$199,946
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S1
|
$100,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-23
|
$5,994,681
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-03S1
|
$91,667
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-03
|
$1,463,613
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Colorado Southwest Oncology Group
|
2U10CA042777-23
|
$231,603
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-15S1
|
$99,999
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
5P30CA062203-15
|
$1,304,625
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$272,277
|
Fowler, Daniel
|
CCR (NCI)
|
|
Understanding Hemotopoietic Neoplasias using Humanized Mice
|
1R01CA156689-01
|
$531,609
|
FLAVELL, RICHARD
|
YALE UNIVERSITY
|
|
Uncoupling of Jak/STAT in HTLV-1 associated leukemia
|
5R01CA115398-04
|
$223,440
|
NICOT, CHRISTOPHE
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
UMass Boston-DF/HCC U54 Partnership (2 of 2)
|
1U54CA156734-01
|
$1,279,856
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY
|
4R33CA116127-03
|
$899,727
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
|
5R01CA118085-05
|
$290,571
|
ZHOU, PENGBO
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
U10 Full Member Application Affiliated with SWOG
|
2U10CA105409-07
|
$325,685
|
HERBST, ROY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|